Seismic Therapeutic Closes $121M Series B Financing

Cambridge, MA, December 4, 2023 (Business Wire) -- Seismic Therapeutic, Inc., the machine learning immunology company, has announced the completion of a $121 million Series B financing. The Series B was led by new investor Bessemer Venture Partners with participation from other new investors, including Amgen Ventures, Codon Capital, Alexandria Venture Investments, Gaingels, and GC&H.

Read full article here.